Tag Archives: National Neuro Advisory Group

Pan-Neurological Statistics for England (Neurological Alliance)

Posted on April 2, 2019 by Dementia and Elderly Care News

Summary The Neurological Alliance’s latest report provides a round-up of estimates for the prevalence of a range of neurological disorders. There are about 14.7 million neurological cases (one in six people) in the UK, and yet: “ …the NHS Long … Continue reading →

Posted in Acute Hospitals, Charitable Bodies, Commissioning, Community Care, For Carers (mostly), For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), Management of Condition, National, NHS, NHS England, Person-Centred Care, Public Health England, Quick Insights, Statistics, UK, Universal Interest | Tagged Acoustic Neuroma, Action Duchenne, Action for M.E., Alzheimer’s Research UK, Ataxia, Ataxia UK, Autism, Autistica, Avoidable Premature Mortality, Awareness, Awareness and Campaigns, Awareness of Neurological Conditions, Awareness Raising, Batten Disease, Batten Disease Family Association, Brain Awareness Week, Brain Awareness Week (2019), Brain Tumour Charity, British Acoustic Neuroma Association, Carpal Tunnel Syndrome, Cavernoma, Cavernoma Alliance UK, Cerebral Palsy, Charcot-Marie-Tooth Disease, Charcot-Marie-Tooth UK, Chronic Fatigue Syndrome (ME), Chronic Inflammatory Demyelinating Polyneuropathy, Cluster Headache, CNS and Other Intracranial Tumours, Cost(s) of Neurological Conditions, Daisy Garland, Dementia, Different Strokes, Dystonia, Dystonia Society, Encephalitis, Encephalitis Society, Epidemiology of Major Neurological Disorders, Epidemiology of Major Neurological Disorders in United Kingdom, Epilepsy, Epilepsy Action, Epilepsy Research UK, Essential Tremor, Fibromyalgia, FND Action, FND Hope, Functional Neurological Disorder, Geographical Variations, Getting It Right First Time (GIRFT), Guillain-Barré Syndrome, Guillain-Barre and Associated Inflammatory Neuropathies, Health Inequalities, Health Inequalities in England, Hemihelp, Hemiplegia, Huntington’s Disease, Huntington’s Disease Association, Hydrocephalus, Idiopathic Intracranial Hypertension, IIH UK, Improving Healthcare to Reduce Premature Mortality in People with Neurological Disorders, Katharine McIntosh: Senior Policy Advisor at Neurological Alliance, Living With Neurological Conditions, Local Health Services: Variations, Long Term Neurological Conditions, Meningitis, Migraine, Migraine Trust, Motor Neurone Disease, Motor Neurone Disease Association, MS Society, Multiple Sclerosis, Multiple System Atrophy, Multiple System Atrophy Trust, Muscular Dystrophy, Muscular Dystrophy UK, Myasthenias, Myaware, Myelopathy, Myelopathy.org, Narcolepsy, Narcolepsy UK, National Neuro Advisory Group, National Tremor Foundation, Nerve Tumours UK, Neurofibromatosis, Neurological Alliance, Neurological Conditions, Neurological Disorders, Neurological Disorders and Health Inequalities, Neurology Intelligence Collaborative, Neurology Intelligence Network (NIN), Neuromyelitis Optica, NHS Outcomes Framework (NHSOF), NHS Outcomes Framework Domains, Organisation for the Understanding of Cluster Headache (OUCH UK), Other Neurological Conditions, Pan-Neurological Priorities for Commissioning, Parkinson's Disease, Parkinson’s UK, PHE Neurology Intelligence Network (NIN), Polio Survivors Network, Post-Polio Syndrome, Premature Mortality, Prevalence and / or Incidence of Acoustic Neuroma, Prevalence and / or Incidence of Ataxia, Prevalence and / or Incidence of Autism, Prevalence and / or Incidence of Batten Disease, Prevalence and / or Incidence of Carpal Tunnel Syndrome, Prevalence and / or Incidence of Cavernoma, Prevalence and / or Incidence of Cerebral Palsy, Prevalence and / or Incidence of Charcot-Marie-Tooth Disease, Prevalence and / or Incidence of Chronic Fatigue Syndrome (ME), Prevalence and / or Incidence of Chronic Inflammatory Demyelinating Polyneuropathy, Prevalence and / or Incidence of Cluster Headache, Prevalence and / or Incidence of CNS and Other Intracranial Tumours, Prevalence and / or Incidence of Dementia, Prevalence and / or Incidence of Dystonia, Prevalence and / or Incidence of Encephalitis, Prevalence and / or Incidence of Epilepsy, Prevalence and / or Incidence of Essential Tremor, Prevalence and / or Incidence of Fibromyalgia, Prevalence and / or Incidence of Functional Neurological Disorder, Prevalence and / or Incidence of Guillain-Barre Syndrome, Prevalence and / or Incidence of Hemiplegia, Prevalence and / or Incidence of Huntington’s Disease, Prevalence and / or Incidence of Hydrocephalus, Prevalence and / or Incidence of Idiopathic Intracranial Hypertension, Prevalence and / or Incidence of Meningitis, Prevalence and / or Incidence of Migraine, Prevalence and / or Incidence of Motor Neurone Disease, Prevalence and / or Incidence of Multiple Sclerosis, Prevalence and / or Incidence of Multiple System Atrophy, Prevalence and / or Incidence of Muscular Dystrophy, Prevalence and / or Incidence of Myasthenias, Prevalence and / or Incidence of Myelopathy, Prevalence and / or Incidence of Narcolepsy, Prevalence and / or Incidence of Neurofibromatosis, Prevalence and / or Incidence of Neuromyelitis Optica, Prevalence and / or Incidence of Parkinsons Disease, Prevalence and / or Incidence of Post-Polio Syndrome, Prevalence and / or Incidence of Progressive Supranuclear Palsy, Prevalence and / or Incidence of Restless Legs Syndrome, Prevalence and / or Incidence of Rett Syndrome, Prevalence and / or Incidence of Spina Bifida, Prevalence and / or Incidence of Spinal Cord Injury, Prevalence and / or Incidence of Spinal Muscular Atrophy, Prevalence and / or Incidence of Stroke - Ischaemic and Haemorrhagic, Prevalence and / or Incidence of Tourette Syndrome, Prevalence and / or Incidence of Transverse Myelitis, Prevalence and / or Incidence of Traumatic Brain Injury, Prevalence and / or Incidence of Trigeminal Neuralgia, Prevalence and / or Incidence of Tuberous Sclerosis Complex, Prevalence and Incidence of Neurological Conditions, Prevalence of Neurological Conditions, Prevalence of Neurological Disorders, Progressive Supranuclear Palsy, PSP Association, Public Health England (PHE) Neurology Intelligence Network (NIN), Reducing Avoidable Premature Mortality, Reducing Health Inequalities, Reducing Premature Mortality, Reducing Variation, Restless Legs Syndrome, Restless Legs Syndrome UK, Rett Syndrome, Rett UK, Sarah Vibert: Chief Executive of Neurological Alliance, Scope, Shine Charity, SMA Support UK, Spina Bifida, Spinal Cord Injury, Spinal Injuries Association, Spinal Muscular Atrophy, Spotlight Young Onset Parkinsons, Stroke - Ischaemic and Haemorrhagic, Stroke Association, SUDEP Action, Tourette Syndrome, Tourettes Action, Transverse Myelitis, Tranverse Myelitis Society, Traumatic Brain Injury, Trigeminal Neuralgia, Trigeminal Neuralgia Association UK, Tuberous Sclerosis Association, Tuberous Sclerosis Complex, UKABIF, Unacceptable Variations, Variations in Service, Variety of Neurological Conditions, Versus Arthritis | Leave a comment